Skip to main content

J.P. Morgan Keeps Their Buy Rating on Bayer (0P6S)

Tipranks - Tipranks - Tue Jan 20, 3:12AM CST

In a report released today, Richard Vosser from J.P. Morgan maintained a Buy rating on Bayer, with a price target of €50.00.

Claim 50% Off TipRanks Premium

Vosser covers the Healthcare sector, focusing on stocks such as Roche Holding AG, AstraZeneca, and Merck KGaA. According to TipRanks, Vosser has an average return of 3.0% and a 51.48% success rate on recommended stocks.

In addition to J.P. Morgan, Bayer also received a Buy from Kepler Capital ‘s Christian Faitz in a report issued on January 13. However, today, Jefferies maintained a Hold rating on Bayer (LSE: 0P6S).

See today’s best-performing stocks on TipRanks >>

Based on Bayer’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of €9.66 billion and a GAAP net loss of €963 million. In comparison, last year the company earned a revenue of €9.97 billion and had a GAAP net loss of €4.18 billion

Read More on GB:0P6S:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).